These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 17906685)

  • 1. Efficacy of small-molecule glycogen synthase kinase-3 inhibitors in the postnatal rat model of tau hyperphosphorylation.
    Selenica ML; Jensen HS; Larsen AK; Pedersen ML; Helboe L; Leist M; Lotharius J
    Br J Pharmacol; 2007 Nov; 152(6):959-79. PubMed ID: 17906685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of glycogen synthase kinase-3 reverses tau hyperphosphorylation induced by Pin1 down-regulation.
    Xiong YS; Wang DL; Tan L; Wang X; Chen LM; Gong CX; Wang JZ; Zhu LQ
    CNS Neurol Disord Drug Targets; 2013 May; 12(3):436-43. PubMed ID: 23469846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lithium inhibits neurite growth and tau protein kinase I/glycogen synthase kinase-3beta-dependent phosphorylation of juvenile tau in cultured hippocampal neurons.
    Takahashi M; Yasutake K; Tomizawa K
    J Neurochem; 1999 Nov; 73(5):2073-83. PubMed ID: 10537067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of glycogen synthase kinase-3β by Angelica sinensis extract decreases β-amyloid-induced neurotoxicity and tau phosphorylation in cultured cortical neurons.
    Zhang Z; Zhao R; Qi J; Wen S; Tang Y; Wang D
    J Neurosci Res; 2011 Mar; 89(3):437-47. PubMed ID: 21259330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 17beta-estradiol attenuates glycogen synthase kinase-3beta activation and tau hyperphosphorylation in Akt-independent manner.
    Shi HR; Zhu LQ; Wang SH; Liu XA; Tian Q; Zhang Q; Wang Q; Wang JZ
    J Neural Transm (Vienna); 2008 Jun; 115(6):879-88. PubMed ID: 18217188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LiCl attenuates thapsigargin-induced tau hyperphosphorylation by inhibiting GSK-3β in vivo and in vitro.
    Fu ZQ; Yang Y; Song J; Jiang Q; Lin ZC; Wang Q; Zhu LQ; Wang JZ; Tian Q
    J Alzheimers Dis; 2010; 21(4):1107-17. PubMed ID: 21504119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective loss of basal forebrain cholinergic neurons by 192 IgG-saporin is associated with decreased phosphorylation of Ser glycogen synthase kinase-3beta.
    Hawkes C; Jhamandas JH; Kar S
    J Neurochem; 2005 Oct; 95(1):263-72. PubMed ID: 16181430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of glycogen synthase kinase-3beta downregulates total tau proteins in cultured neurons and its reversal by the blockade of protein phosphatase-2A.
    Martin L; Magnaudeix A; Esclaire F; Yardin C; Terro F
    Brain Res; 2009 Feb; 1252():66-75. PubMed ID: 19071093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overactivation of glycogen synthase kinase-3 by inhibition of phosphoinositol-3 kinase and protein kinase C leads to hyperphosphorylation of tau and impairment of spatial memory.
    Liu SJ; Zhang AH; Li HL; Wang Q; Deng HM; Netzer WJ; Xu H; Wang JZ
    J Neurochem; 2003 Dec; 87(6):1333-44. PubMed ID: 14713290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo activation and nuclear translocation of phosphorylated glycogen synthase kinase-3beta in neuronal apoptosis: links to tau phosphorylation.
    Elyaman W; Terro F; Wong NS; Hugon J
    Eur J Neurosci; 2002 Feb; 15(4):651-60. PubMed ID: 11886446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perinatal exposure to lead (Pb) promotes Tau phosphorylation in the rat brain in a GSK-3β and CDK5 dependent manner: Relevance to neurological disorders.
    Gąssowska M; Baranowska-Bosiacka I; Moczydłowska J; Tarnowski M; Pilutin A; Gutowska I; Strużyńska L; Chlubek D; Adamczyk A
    Toxicology; 2016 Mar; 347-349():17-28. PubMed ID: 27012722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of zinc-induced phosphorylation of p70 S6 kinase and glycogen synthase kinase 3beta in SH-SY5Y neuroblastoma cells.
    An WL; Bjorkdahl C; Liu R; Cowburn RF; Winblad B; Pei JJ
    J Neurochem; 2005 Mar; 92(5):1104-15. PubMed ID: 15715661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SLM, a novel carbazole-based fluorophore attenuates okadaic acid-induced tau hyperphosphorylation via down-regulating GSK-3β activity in SH-SY5Y cells.
    Wu X; Kosaraju J; Tam KY
    Eur J Pharm Sci; 2017 Dec; 110():101-108. PubMed ID: 28359686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bip enhanced the association of GSK-3β with tau during ER stress both in vivo and in vitro.
    Liu ZC; Fu ZQ; Song J; Zhang JY; Wei YP; Chu J; Han L; Qu N; Wang JZ; Tian Q
    J Alzheimers Dis; 2012; 29(4):727-40. PubMed ID: 22460328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon-like peptide-1 protects hippocampal neurons against advanced glycation end product-induced tau hyperphosphorylation.
    Chen S; An FM; Yin L; Liu AR; Yin DK; Yao WB; Gao XD
    Neuroscience; 2014 Jan; 256():137-46. PubMed ID: 24183963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Wnt pool of glycogen synthase kinase 3beta is critical for trophic-deprivation-induced neuronal death.
    Hongisto V; Vainio JC; Thompson R; Courtney MJ; Coffey ET
    Mol Cell Biol; 2008 Mar; 28(5):1515-27. PubMed ID: 18195042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular α-synuclein leads to microtubule destabilization via GSK-3β-dependent Tau phosphorylation in PC12 cells.
    Gąssowska M; Czapski GA; Pająk B; Cieślik M; Lenkiewicz AM; Adamczyk A
    PLoS One; 2014; 9(4):e94259. PubMed ID: 24722055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide induces tau hyperphosphorylation via glycogen synthase kinase-3beta activation.
    Zhang YJ; Xu YF; Liu YH; Yin J; Wang JZ
    FEBS Lett; 2005 Nov; 579(27):6230-6. PubMed ID: 16253246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Wnt and PI3K signaling modulates GSK-3beta activity and induces morphological changes in cortical neurons: role of tau phosphorylation.
    Mercado-Gómez O; Hernández-Fonseca K; Villavicencio-Queijeiro A; Massieu L; Chimal-Monroy J; Arias C
    Neurochem Res; 2008 Aug; 33(8):1599-609. PubMed ID: 18461448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of tau protein kinase I/glycogen synthase kinase-3beta, phosphatases 2A and 2B, and phosphorylated tau in the developing rat brain.
    Takahashi M; Tomizawa K; Ishiguro K
    Brain Res; 2000 Feb; 857(1-2):193-206. PubMed ID: 10700568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.